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ABSTRACT 
 
Purpose: Optimal strategies for reducing catheter-related blood stream infection (CR-BSI) 
differ for adults and children. National guidelines do not make child-specific 
recommendations. We determined whether evidence explained inconsistencies between 
guidelines and reported practice in Paediatric Intensive Care Units (PICUs).  
 
Methods: We conducted a survey of eight interventions for reducing CR-BSI in all 25 British 
PICUs, 2009. Interventions were categorised as requiring child-specific evidence, 
generalisable to adults and children, or organisational recommendations.  
 
Results: 24/25 PICUs responded.  
 
For child-specific interventions, practice diverged from guidelines for “Insert into 
subclavian/jugular veins” (18 PICUs frequently used femoral veins, supported by 
observational evidence for increased safety in children). Practice reflected guidelines for: 
“Use standard but consider antimicrobial-impregnated CVCs for high-risk patients” (14 used 
standard only, 3 used standard and antimicrobial-impregnated despite no RCT evidence for 
antimicrobial-impregnated CVCs in children, 7 used heparin-bonded for some or all children); 
“Use 2% chlorhexidine for skin preparation” (20 PICUs); “Avoid routine CVC replacement” 
(20 PICUs).  
 
For generalisable interventions, practice was consistent with guidelines for “Administration 
set replacement” (21 PICUs) but deviated for “Maintenance of CVC asepsis” (11 PICUs used 
alcohol due to inconclusive evidence for chlorhexidine). Practice diverged from guidelines for 
organisational interventions: “Train healthcare workers in CVC-care” (9 PICUs); “Monitor 
BSI rates” (8 PICUs). 
  
Conclusions: Guidelines should explicitly address paediatric practice and report quality of 
evidence and strength of recommendations. Organisations should ensure doctors are trained in 
CVC-insertion and invest in BSI monitoring, especially in PICU. Type of CVC and insertion 
site are important gaps in evidence for children. 
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Central venous catheters (CVCs) are widely used in the NHS with an estimated 238,000 
inserted each year [1]. CVCs are associated with an increased risk of nosocomial blood 
stream infection (BSI), an important cause of mortality, morbidity, increased length of stay 
and substantial extra cost for paediatric patients [2-6]. An estimated 70% of nosocomial BSI 
in Paediatric Intensive Care Units (PICU) is caused by CVCs, with PICUs having the second 
highest rate of nosocomial BSI of all specialties (7.9 BSI per 1000 patient-days) [7].  
 
Evidence from cohort studies and time series analyses shows that improving multiple 
elements of CVC insertion, access and maintenance can successfully reduce the rates of 
catheter-related BSI (CR-BSI) in PICU [8-11]. Maintenance care bundles have been found to 
be even more important than insertion care bundles for reducing CR-BSI in the paediatric 
setting [12]. Since 2005, campaigns to reduce CR-BSI rate across all specialties have been 
launched in the UK, including the Department of Health’s (DoH) Saving Lives care bundle  
based on the epic2 guidelines (National Evidence-Based Guidelines for Preventing 
Healthcare-Associated Infections in NHS Hospitals in England), and the Matching Michigan 
scheme (http://www.nrls.npsa.nhs.uk/matchingmichigan/), based on a successful evidence-
based intervention in Michigan ICUs [13-15].  
 
The DoH guidelines apply to all patients, whereas US guidelines recognise the specific 
considerations needed for the prevention of CR-BSI in children [16, 17]. For example, CVCs 
are more difficult to insert in children compared with adults due to smaller veins and they are 
often left in for longer periods of time due to difficulties in venous access [11]. In addition, 
the femoral vein is considered to be safer in children for emergency CVC insertion.  
 
We hypothesised that divergence between national guidelines and reported practice in the UK 
might be explained by evidence specific to the paediatric setting. We selected eight 
interventions to reduce CR-BSI, and grouped interventions into those requiring paediatric 
specific evidence, those where recommendations could be generalised across adult and 
paediatric populations, and non-clinical recommendations that require implementation at an 
organisational level. 
  
Methods: 
 
We developed a 20-question survey about interventions to reduce CR-BSI and current CVC 
practice, including four open questions on factors impacting on infection control in PICUs 
and estimated rates of bacteraemia (available from the authors).The questionnaire was piloted 
on four clinicians prior to sending by email or post to a designated consultant at each of the 25 
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PICUs in the Paediatric Intensive Care Audit Network (PICANet) in Great Britain. Repeated 
requests were made to non-responders and responders with missing data. Responses were 
collected between January and October 2009. 
 
We defined interventions that required child-specific evidence, according to the principles of 
the Cochrane Applicability and Recommendations Methods Group 
(http://armg.cochrane.org), as those where physiological or technical reasons cause different 
benefits or harms, where different and identifiable factors may cause effect modification, or 
where clinically important differences in absolute risk exist, in children compared with adults. 
We classified four of the eight interventions as requiring child specific evidence, two as being 
generalisable to children and adults, and two as organisational interventions requiring 
evidence comparing teams or hospitals (see Table 1). Categorisation was implemented post 
data collection. 
Table 1: Guidelines and categorisation for eight interventions 
 Intervention Guideline [13, 14] Categorisation 
1) Insertion site Use subclavian or internal jugular veins – avoid femoral. Child-specific 
2) Type of CVC Use standard CVC but consider antimicrobial 
impregnated catheter if duration 1 to 3 weeks or risk of 
CR-BSI high. 
Child-specific 
3) Skin preparation Use 2% chlorhexidine gluconate in 70% isopropyl 
alcohol and allow to dry. 
Child-specific 
4) Avoid routine 
catheter 
replacement 
Check if still required daily. Child-specific 
    
5) Administration 
set replacement 
Replace administration set following total parenteral 
nutrition – after 24 hours (72 hours if no lipid). With 
other  fluid  sets –  replace after  a maximum  of  72 
hours. 
Generalisable 
6) Maintenance of 
CVC asepsis 
Use aseptic technique and swab ports or hub with 2% 
chlorhexidine gluconate in 70% isopropyl alcohol prior to 
accessing the line for administering fluids or injections. 
Generalisable 
    
7) Training in CVC 
care 
Healthcare workers caring for a patient with a central 
venous access device should be trained and assessed. 
Organisational 
8) Monitor BSI 
rates 
Monitor BSI rates to identify lapses in infection-control 
practices. 
Organisational 
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For child-specific interventions, guidelines were classified as consistent with evidence if the 
guideline followed the best available evidence for children. All other guidelines were 
classified as consistent with evidence if the guideline followed the best available evidence. 
Consistency between reported practice and guidelines was categorised as a) majority of 
PICUs reporting practice consistent with guidelines, b) majority of PICUs reporting practice 
diverging from guidelines, or c) majority of PICUs reporting practice diverging from 
guidelines but consistent with best available evidence. For intervention 2) Type of CVC, we 
determined that practice was consistent with guidelines if PICUs followed the primary 
recommendation (use standard) or both the primary and secondary recommendations (use 
standard / consider antimicrobial-impregnated). 
 
The guidelines evaluated were those from the DoH Saving Lives care bundle and the epic2 
guidelines. Guidelines were appraised by a search of all evidence referenced within their 
documentation [13, 14]. For child-specific interventions, we updated the reported searches by 
searching PubMed using search terms and synonyms for child, paediatric, intensive care and 
individual interventions. To evaluate the best available evidence underpinning guidelines, we 
classified studies into randomised controlled trials (RCTs) and observational studies. For the 
organisational interventions “Training in CVC care” and “Monitor BSI rates”, RCTs may not 
be available and so we accepted observational evidence for these interventions. We evaluated 
the quality of all evidence using standard criteria for internal validity [18]. 
 
 
Results: Responses were received from 24 of the 25 PICUs (96%). The majority of units 
estimated that 51-75% of emergency and 76-100% of post-operative admissions required a 
polyurethane CVC during their admission to PICU. Further results relating to each 
intervention are shown in Tables 2, 3 and 4. 
 
TABLES 2-4 HERE 
 
Thirteen PICUs reported a decline in nosocomial bacteraemia over the preceding two years. 
In response to being asked for any aspects of infection control considered to have had 
a significant impact on BSI in patients with a CVC, PICUs stated that factors 
contributing to declining infection rates included strict adherence to insertion asepsis, the 
introduction of CVC care bundles, use of 2% chlorhexidine, use of heparin-bonded or 
antibiotic-impregnated CVCs, nurse training, early removal of CVCs when not required, and 
auditing of hand-hygiene. 
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Table 2: Evidence, reported practice and guidelines requiring child-specific evidence for clinical interventions 
= Reported practice consistent with guidelines, X = Reported practice diverged from guidelines, † = Reported practice diverged from guidelines but consistent with best available evidence. 
 Reported Practice Evidence Consistency 
1
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In emergency patients, the femoral 
site was used more than 50% of the 
time in 18/21 PICUs. In post-
operative patients, the internal 
jugular site was used more than 
50% of the time in 12/20 PICUs  
 
Systematic reviews found no RCTs comparing subclavian, 
jugular and femoral sites for CR-BSI or venous thrombosis 
in children (one RCT favoured the subclavian site 
compared with the femoral for adults) [19-21].  
 
In children, observational studies suggest a similar risk  of 
infection with femoral and non-femoral catheters, increased 
safety with femoral insertion sites  compared with 
subclavian or jugular sites and greater ease of insertion in 
emergency situations [22-24].  
Evidence: RCT evidence of benefit for adults, weak 
observational evidence of harm for children.  
 
Guideline: Does not follow best available evidence for 
children. 
 
Practice: Majority (18/21) of PICUs were consistent with 
best available evidence but inconsistent with guidelines. 
 
† 
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Standard CVCs were used for all 
patients in 14/24 PICUs. A further 
3/24 PICUs used standard and 
antibiotic-impregnated CVCs.  
 
Heparin-bonded CVCs were used 
for all patients in 3/24 PICUs. A 
further 4/24 PICUs used standard 
and heparin-bonded CVCs.  
Systematic reviews of RCTs show antibiotic-impregnated 
CVCs significantly reduce CR-BSI in adults, but there are 
no RCTs of antibiotic-impregnated CVCs in children [25].  
 
RCTs and cost-effectiveness studies have shown large 
benefits of heparin-bonded CVCs regardless of risk status 
[25]. 
Evidence: Strong RCT evidence of benefit for antibiotic-
impregnated CVCs in adults but a lack of evidence for 
children. Strong RCT evidence of benefit for heparin-
bonded CVCs in children. 
 
Guideline: Does not follow best evidence for children. 
 
Practice: Majority of PICUs (17/24) were consistent with 
guidelines.  3/24 PICUs consistent with best available 
evidence contrary to the guidelines. 
  
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19 and 20/24 responders in 
emergency and postoperative 
admissions respectively used 2% 
chlorhexidine to clean the skin 
prior to CVC insertion.  
 
Practice for neonates was not 
separately recorded.  
 
 
A meta-analysis of RCTs indicated that use of 
chlorhexidine reduced the risk of CR-BSI by an estimated 
49% for short-term catheterisation compared with 
povidone–iodine [26, 27]. 
 
Evidence for paediatric patients is lacking [28]. One RCT in 
neonates found chlorhexidine gluconate more effective than 
povidone-iodine in reducing CVC tip colonization in NICU, 
and an observational study found chlorhexidine to be more 
effective than povidone-iodine in children on long-term 
haemodialysis [29, 30]. Cases of skin irritation have been 
reported with 2% chlorhexidine for preterm and very low 
birth weight neonates [31, 32]. 
Evidence: Strong RCT evidence of benefit for adults, weak 
RCT evidence of benefit for children and observational 
evidence of harm for preterm and very low birth weight 
babies.  
 
Guideline: Follows best evidence for adults and children, 
but does not address harms for neonates. 
 
Practice: Majority of PICUs (20/24) were consistent with 
guidelines and best available evidence. Consistency with 
evidence is unknown for neonates. 
  
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CVCs were not routinely replaced 
after seven days by 20/24 PICUs 
unless under special 
circumstances. CVCs were 
routinely replaced after seven days 
in 4/24 PICUs. Only 12/24 
responders reported a system for 
daily recording of the need for 
CVC. 
Systematic reviews of RCTs show no benefit of routine 
replacement of CVCs to reduce infection in children or 
adults [33, 34]. 
 
Evidence: Strong RCT evidence of no benefit of routine 
replacement for adults or children. 
 
Guideline: Follows best evidence for adults and children. 
 
Practice: Majority of PICUs (20/24) were consistent with 
evidence and guidelines.  
  
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Table 3: Evidence, reported practice and guidelines generalisable to adults and children for clinical interventions  
= Reported practice consistent with guidelines, X = Reported practice diverged from guidelines, † = Reported practice diverged from guidelines but consistent with best available evidence. 
 Reported Practice Evidence Consistency 
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Administration sets for total parenteral 
nutrition were reported to be changed 
every 24 hours by almost all (21/24) 
responders, every 48 hours by 1/24, 
every 72 hours by 1/24, and routinely 
less often than 72 hours by 1/24. 
Administration sets for fluids and 
medications were reported to be 
changed every 24 hours by 20/24 
responders, every 48 hours by 1/24 and 
every 72 hours by 3/24. 
A Cochrane review found that administration sets 
that do not contain lipids, blood or blood products 
may be left in place for up to 96 hours, and 
administration sets which contain lipids should be 
changed every 24 hours, with no differences between 
children and adults [35]. 
 
Evidence: Strong RCT evidence of benefit. 
 
Guideline: Follows best available evidence. 
 
Practice: Majority of PICUs (21/24) were consistent with 
evidence and guidelines.   
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12/24 PICUs used 2% chlorhexidine in 
alcohol to clean hubs prior to CVC 
access; 1 PICU used 0.5% 
chlorhexidine; 11 used alcohol.  
 
 
Guidelines are based on one RCT in adults that 
found needle-less connectors disinfected with 
alcohol had significantly higher rates of 
contamination compared with those disinfected with 
chlorhexidine/alcohol or povidone-iodine (69.2%, 
30.8% and 41.6% respectively) [36]. 
Evidence: Inconclusive evidence of benefit. 
  
Guideline: Based on inconclusive evidence. 
 
Practice: Half (12/24) of the PICUs were consistent with 
guidelines. 
X 
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Table 4: Evidence, reported practice and guidelines for organisational interventions 
= Reported practice consistent with guidelines, X = Reported practice diverged from guidelines, † = Reported practice diverged from guidelines but consistent with best available evidence. 
 Reported Practice 
Evidence Consistency 
7. Training 
in CVC 
care 
A small proportion of responders held 
specific training sessions on CVC insertion 
for doctors (9 and 7/24 responders for 
emergency and post-operative admissions 
respectively), whilst 22/23 responders had 
dedicated training sessions on CVC care for 
nurses. 
The effectiveness of training in insertion and 
maintenance of CVCs for reducing complications 
relating to CVCs has been well documented 
through observational studies. Before-after studies 
have shown systematic interventions of education 
in combination with care bundles reduced 
infection rates by 23-37% in paediatric settings [9, 
37].  
Evidence: Strong observational evidence for benefit. 
 
Guideline: Follows best available evidence. 
 
Practice: Less than half (9/24) of the PICUs were 
consistent with available evidence and guidelines for 
doctors; the majority (22/24) were consistent for 
nurses. 
X 
8. 
Monitoring 
BSI 
Six PICUs monitored BSI rates by catheter-
day (ranging from 0-6.3 per 1000 catheter-
dates) and a further 2 PICUs monitored BSI 
per patient (0.5-11.8% of patients). There 
was no routine recording of BSI rates in the 
remaining 16/24 PICUs. Nine responders 
stated that rates had remained the same over 
the past two years; 13 thought rates had 
decreased; the remaining 2 did not know. 
Guidelines are based on the National Nosocomial 
Infections Surveillance (NNIS) at the Centers for 
Disease Control and Prevention (CDC) [38]. This 
system has shown substantial improvements in 
infection control within NNIS hospitals. 
Surveillance systems have been shown to improve 
quality of care and to be critical for assessing 
effectiveness of interventions, although they have 
also been associated with higher rates of BSI in 
PICU [39-42]. 
Evidence: Inconclusive observational evidence for 
benefit.  
 
Guideline: Follows best available evidence. 
 
Practice: Majority (16/24) of PICUs were 
inconsistent with best available evidence and 
guidelines. 
X 
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Discussion 
 
National guidelines for reducing the risk of BSI are not child-specific, yet for certain 
recommendations, physiological or technical reasons mean that benefits or harms might differ 
in children compared with adults. For the four clinical interventions that required child-
specific evidence, guidelines were supported by evidence of effectiveness, including safety in 
children, for only two of the interventions. Reported practice was consistent with guidelines 
for these two interventions. In contrast, lack of child-specific evidence on which to base 
guidelines explains why many PICUs choose to follow best available evidence contrary to 
guidelines for site of CVC insertion and type of CVC inserted. Without high quality evidence 
supporting these guidelines, potential benefits or harms to children are uncertain. Reported 
practice also deviated from guidelines for one clinical intervention that did not require child-
specific evidence but for which the evidence base was poor (swab hub with 2% chlorhexidine 
alcohol prior to access).  
 
Evidence from clinicians and research is needed to assess whether physiological or technical 
factors could lead to different benefits or harms, whether there is any evidence of effect 
modification of the interventions in children, and whether there are clinically important 
differences in the absolute risks of beneficial and/or harmful outcomes [43, 44]. Interventions 
based on high quality evidence in adults should not automatically be recommended for 
children and guidelines should be clear about areas of uncertainty and very careful when 
extrapolating evidence from adults to children [45]. 
 
Our findings emphasised the challenge in implementing evidence-based interventions at an 
organisational level, even where strong evidence already exists, such as for monitoring of BSI 
and staff training in CVC care [41]. Discrepancies between evidence and practice for these 
interventions may reflect the greater difficulties of overcoming system and organisational 
barriers to achieve evidence-based, institutional interventions compared with individual 
clinician or team-based decisions. Adoption of organisational interventions can be promoted 
by PICU clinicians but requires commitment from the top of the organisation and 
infrastructure. For example, establishing BSI surveillance could require considerable 
investment of staff time but measures of BSI both within and between units over time could 
be achieved through improving the feedback from the existing national surveillance system of 
BSI operated by the Health Protection Agency. This would overcome difficulties in obtaining 
consistent and meaningful measures for BSI rates across NHS PICUs [46].  
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This is the first survey conducted in the UK to assess variations in practice and adherence to 
multiple guidelines for reducing the risk of catheter-related infection in PICUs. The survey is 
limited in revealing only reported practice, although the Matching Michigan initiative may 
give a clearer picture of actual versus recommended practice in the future. 
 
Our survey identified important areas of uncertainty and inconclusive evidence. Guidelines 
and reported practice in some PICUs diverged from best available evidence regarding the 
safety and effectiveness of heparin-bonded CVCs for reducing BSI. This question is currently 
being addressed by a large multi-centre RCT to determine the effectiveness of antibiotic-
impregnated and heparin-bonded compared with standard CVCs (CATCH – CATheter 
infections in CHildren http://www.hta.ac.uk/1867). Research is needed to compare the risk of 
infection with CVC insertion at femoral, subclavian or internal jugular insertion sites, to 
investigate safety of chlorhexidine in neonates, and to assess the optimal time for catheter 
replacement. Hospitals should provide infrastructure to ensure training in optimal CVC care 
and monitoring of infection rates in PICU as these require implementation at an 
organisational level or a change in hospital culture. 
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